Annual ROA
-42.46%
+0.96%+2.21%
31 December 2023
Summary:
BioCryst Pharmaceuticals annual return on assets is currently -42.46%, with the most recent change of +0.96% (+2.21%) on 31 December 2023. During the last 3 years, it has risen by +29.23% (+40.77%). BCRX annual ROA is now -452.86% below its all-time high of -7.68%, reached on 31 December 2001.BCRX ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-25.05%
+4.02%+13.83%
30 September 2024
Summary:
BioCryst Pharmaceuticals quarterly return on assets is currently -25.05%, with the most recent change of +4.02% (+13.83%) on 30 September 2024. Over the past year, it has increased by +19.19% (+43.38%). BCRX quarterly ROA is now -820.96% below its all-time high of -2.72%, reached on 30 September 2001.BCRX Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCRX ROA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +2.2% | +43.4% |
3 y3 years | +40.8% | +70.4% |
5 y5 years | +31.8% | +75.1% |
BCRX ROA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -6.4% | +40.8% | at high | +70.4% |
5 y | 5 years | -6.4% | +40.8% | at high | +75.1% |
alltime | all time | -452.9% | +40.8% | -821.0% | +75.1% |
BioCryst Pharmaceuticals ROA History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -25.05%(-13.8%) |
June 2024 | - | -29.07%(-29.0%) |
Mar 2024 | - | -40.94%(-5.0%) |
Dec 2023 | -42.46%(-2.2%) | -43.08%(-2.6%) |
Sept 2023 | - | -44.24%(-3.1%) |
June 2023 | - | -45.65%(+7.2%) |
Mar 2023 | - | -42.58%(-5.8%) |
Dec 2022 | -43.42%(+8.8%) | -45.18%(+14.5%) |
Sept 2022 | - | -39.45%(-18.4%) |
June 2022 | - | -48.32%(-3.2%) |
Mar 2022 | - | -49.91%(-5.1%) |
Dec 2021 | -39.89%(-44.4%) | -52.58%(-37.9%) |
Sept 2021 | - | -84.72%(+1.9%) |
June 2021 | - | -83.15%(-9.0%) |
Mar 2021 | - | -91.35%(+3.7%) |
Dec 2020 | -71.69%(+6.0%) | -88.10%(+11.9%) |
Sept 2020 | - | -78.75%(-0.8%) |
June 2020 | - | -79.37%(-9.1%) |
Mar 2020 | - | -87.32%(+7.7%) |
Dec 2019 | -67.61%(+8.5%) | -81.11%(-19.4%) |
Sept 2019 | - | -100.63%(+13.7%) |
June 2019 | - | -88.47%(+24.5%) |
Mar 2019 | - | -71.07%(+10.3%) |
Dec 2018 | -62.29%(+26.9%) | -64.46%(+14.6%) |
Sept 2018 | - | -56.24%(+10.5%) |
June 2018 | - | -50.89%(+1.1%) |
Mar 2018 | - | -50.34%(+7.5%) |
Dec 2017 | -49.07%(-5.6%) | -46.81%(+13.6%) |
Sept 2017 | - | -41.20%(-11.4%) |
June 2017 | - | -46.52%(-0.8%) |
Mar 2017 | - | -46.91%(-16.8%) |
Dec 2016 | -51.97%(+56.6%) | -56.41%(-11.8%) |
Sept 2016 | - | -63.93%(+6.1%) |
June 2016 | - | -60.23%(+53.1%) |
Mar 2016 | - | -39.34%(+24.1%) |
Dec 2015 | -33.19%(-31.8%) | -31.71%(+20.2%) |
Sept 2015 | - | -26.38%(+19.7%) |
June 2015 | - | -22.03%(-48.3%) |
Mar 2015 | - | -42.61%(-4.2%) |
Dec 2014 | -48.66%(-14.1%) | -44.46%(-3.1%) |
Sept 2014 | - | -45.87%(-21.4%) |
June 2014 | - | -58.37%(-24.1%) |
Mar 2014 | - | -76.93%(+25.9%) |
Dec 2013 | -56.64%(+1.2%) | -61.11%(-10.5%) |
Sept 2013 | - | -68.31%(+3.9%) |
June 2013 | - | -65.76%(+13.8%) |
Mar 2013 | - | -57.79%(+6.5%) |
Dec 2012 | -55.97%(-5.8%) | -54.27%(+4.0%) |
Sept 2012 | - | -52.16%(-0.3%) |
June 2012 | - | -52.31%(+1.7%) |
Mar 2012 | - | -51.42%(-6.9%) |
Dec 2011 | -59.43%(+120.8%) | -55.25%(+11.5%) |
Sept 2011 | - | -49.55%(+11.8%) |
June 2011 | - | -44.33%(+17.0%) |
Mar 2011 | - | -37.89%(+35.1%) |
Dec 2010 | -26.91%(+126.9%) | -28.04%(+266.1%) |
Sept 2010 | - | -7.66%(-5.8%) |
June 2010 | - | -8.13%(+11.8%) |
Mar 2010 | - | -7.27%(-54.1%) |
Dec 2009 | -11.86% | -15.83%(-34.7%) |
Sept 2009 | - | -24.26%(+23.1%) |
Date | Annual | Quarterly |
---|---|---|
June 2009 | - | -19.70%(-7.1%) |
Mar 2009 | - | -21.20%(-3.4%) |
Dec 2008 | -21.75%(-20.9%) | -21.94%(-26.6%) |
Sept 2008 | - | -29.91%(-8.3%) |
June 2008 | - | -32.61%(+9.5%) |
Mar 2008 | - | -29.79%(+2.3%) |
Dec 2007 | -27.51%(-47.1%) | -29.13%(-31.0%) |
Sept 2007 | - | -42.21%(-21.2%) |
June 2007 | - | -53.55%(-1.3%) |
Mar 2007 | - | -54.25%(+10.0%) |
Dec 2006 | -52.01%(+31.2%) | -49.34%(-0.2%) |
Sept 2006 | - | -49.46%(+13.2%) |
June 2006 | - | -43.70%(+2.6%) |
Mar 2006 | - | -42.61%(-14.2%) |
Dec 2005 | -39.63%(-41.3%) | -49.66%(-17.4%) |
Sept 2005 | - | -60.14%(+12.7%) |
June 2005 | - | -53.35%(+4.0%) |
Mar 2005 | - | -51.28%(-8.6%) |
Dec 2004 | -67.46%(+89.6%) | -56.08%(+10.6%) |
Sept 2004 | - | -50.72%(+9.7%) |
June 2004 | - | -46.23%(+9.8%) |
Mar 2004 | - | -42.10%(+18.0%) |
Dec 2003 | -35.58%(+5.5%) | -35.68%(+12.4%) |
Sept 2003 | - | -31.74%(+8.1%) |
June 2003 | - | -29.36%(-6.3%) |
Mar 2003 | - | -31.33%(-9.1%) |
Dec 2002 | -33.72%(+339.1%) | -34.47%(-4.0%) |
Sept 2002 | - | -35.89%(+35.0%) |
June 2002 | - | -26.58%(+78.0%) |
Mar 2002 | - | -14.93%(+95.4%) |
Dec 2001 | -7.68%(-52.2%) | -7.64%(+180.9%) |
Sept 2001 | - | -2.72%(-41.1%) |
June 2001 | - | -4.62%(-39.7%) |
Mar 2001 | - | -7.66%(-51.5%) |
Dec 2000 | -16.06%(+55.3%) | -15.78%(+0.4%) |
Sept 2000 | - | -15.72%(-23.4%) |
June 2000 | - | -20.53%(-9.0%) |
Mar 2000 | - | -22.56%(+55.1%) |
Dec 1999 | -10.34%(-40.1%) | -14.55%(-39.4%) |
Sept 1999 | - | -24.02%(+310.6%) |
June 1999 | - | -5.85%(-64.9%) |
Mar 1999 | - | -16.65%(-12.6%) |
Dec 1998 | -17.27%(-48.2%) | -19.06%(-22.2%) |
Sept 1998 | - | -24.51%(-42.2%) |
June 1998 | - | -42.44%(+19.0%) |
Mar 1998 | - | -35.67%(+7.5%) |
Dec 1997 | -33.33%(+8.6%) | -33.17%(+14.2%) |
Sept 1997 | - | -29.05%(-5.9%) |
June 1997 | - | -30.88%(+1.0%) |
Mar 1997 | - | -30.58%(-1.2%) |
Dec 1996 | -30.68%(-53.8%) | -30.95%(-19.0%) |
Sept 1996 | - | -38.20%(-11.3%) |
June 1996 | - | -43.06%(-16.6%) |
Mar 1996 | - | -51.63%(-19.2%) |
Dec 1995 | -66.41%(+23.2%) | -63.89%(+7.4%) |
Sept 1995 | - | -59.51%(+4.1%) |
June 1995 | - | -57.16%(-3.4%) |
Mar 1995 | - | -59.16%(+27.7%) |
Dec 1994 | -53.91% | -46.31%(+41.7%) |
Sept 1994 | - | -32.69%(+49.9%) |
June 1994 | - | -21.81%(+133.0%) |
Mar 1994 | - | -9.36% |
FAQ
- What is BioCryst Pharmaceuticals annual return on assets?
- What is the all time high annual ROA for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual ROA year-on-year change?
- What is BioCryst Pharmaceuticals quarterly return on assets?
- What is the all time high quarterly ROA for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly ROA year-on-year change?
What is BioCryst Pharmaceuticals annual return on assets?
The current annual ROA of BCRX is -42.46%
What is the all time high annual ROA for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual return on assets is -7.68%
What is BioCryst Pharmaceuticals annual ROA year-on-year change?
Over the past year, BCRX annual return on assets has changed by +0.96% (+2.21%)
What is BioCryst Pharmaceuticals quarterly return on assets?
The current quarterly ROA of BCRX is -25.05%
What is the all time high quarterly ROA for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly return on assets is -2.72%
What is BioCryst Pharmaceuticals quarterly ROA year-on-year change?
Over the past year, BCRX quarterly return on assets has changed by +19.19% (+43.38%)